Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

UroGen Pharma (URGN) Asset Utilization Ratio: 2018-2025

Historic Asset Utilization Ratio for UroGen Pharma (URGN) over the last 6 years, with Sep 2025 value amounting to 0.49.

  • UroGen Pharma's Asset Utilization Ratio rose 60.13% to 0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49, marking a year-over-year increase of 60.13%. This contributed to the annual value of 0.39 for FY2024, which is 26.06% down from last year.
  • UroGen Pharma's Asset Utilization Ratio amounted to 0.49 in Q3 2025, which was up 18.69% from 0.41 recorded in Q2 2025.
  • UroGen Pharma's Asset Utilization Ratio's 5-year high stood at 0.70 during Q2 2023, with a 5-year trough of 0.17 in Q1 2021.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.44 (2023), whereas its average is 0.44.
  • In the last 5 years, UroGen Pharma's Asset Utilization Ratio spiked by 907.62% in 2021 and then plummeted by 49.38% in 2024.
  • Over the past 5 years, UroGen Pharma's Asset Utilization Ratio (Quarterly) stood at 0.38 in 2021, then grew by 29.02% to 0.49 in 2022, then dropped by 8.75% to 0.44 in 2023, then crashed by 30.83% to 0.31 in 2024, then surged by 60.13% to 0.49 in 2025.
  • Its last three reported values are 0.49 in Q3 2025, 0.41 for Q2 2025, and 0.34 during Q1 2025.